Category Cardiology Heart Disease
Press Release
AGFA HealthCare Expands the Enterprise Imaging Platform to Cardiology at Zuckerberg San Francisco General Hospital
Breaking down the silos between departments opens up an exciting new level of efficiency, cost savings, communication, and faster, more informed decision-making.
Read More
Press Release
Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models
Following favorable FDA feedback for the treatment of liver disease, the company is preparing further pre-IND meetings with the FDA for the treatment of atherosclerosis and familial hypercholesterolemia Read More
Press Release
Essex Cardiothoracic Centre Earns Award for Atrial Fibrillation Study That Demonstrates StatSeal Efficacy
Study demonstrates efficacy of StatSeal® Advanced Plus Disc use for groin closure following atrial fibrillation ablation procedures to treat patients with irregular heartbeats. Read More
Press Release
AnaBios Boosts Discovery of Safer, More Effective Medicines With License From the University of Louisville
The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the preclinical implementation of advanced human heart models Read More
Press Release
New Intensive Cardiac Rehab Program at Modern Heart and Vascular Institute
Modern Heart and Vascular Institute is proud to offer an intensive cardiac rehabilitation program designed to help patients get back to their normal lives after being diagnosed with cardiovascular disease. Read More
Press Release
Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design
Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction. Read More
Press Release
Dr. Ricardo Bellera, Board-Certified Interventional Cardiologist Joins Modern Heart & Vascular
Ricardo Bellera, MD, joins Modern Heart and Vascular to provide quality heart and vascular care for adults living and working in The Woodlands, Katy, Humble, and greater Houston, Texas, area Read More
Press Release
Retrospective Analysis Using the VoluMetrix NIVA|HF Investigational Algorithm to Assess Patients With Heart Failure Predicts Hospitalization
The NIVA|HF investigational algorithm uses proprietary venous waveform technology from VoluMetrix to assess otherwise hard-to-obtain cardiovascular metrics. According to study authors, 'This non-invasive measurement has potential for … prevention of hospital admission in heart failure patients.' Read More
Press Release
Dr. Percy Morales, Board-Certified Cardiologist & Electrophysiologist, Joins Modern Heart & Vascular
Percy Francisco Morales, MD, joins Modern Heart and Vascular to provide excellent heart health services for adults living and working in Houston, TX, and the surrounding areas. Read More
Press Release
Radcliffe Group Appoints New Editor-in-Chief of Interventional Cardiology Review and Opens Journal to Original Research Through Its Title Change (ICR3)
Interventional Cardiology Review (ICR) journal names Dr Peter O'Kane as ICR's new Editor-in-Chief. Dr O'Kane's term begins July 26, 2021. Read More
Press Release
VoluMetrix's NIVA|HF for Heart Failure Patients Designated as Breakthrough Device by U.S. FDA
NIVA|HF is an investigational device designed to monitor the venous waveform, a novel physiologic signal, in heart failure patients. As a Breakthrough Device, NIVA|HF will receive pre-market developmental assistance and prioritized regulatory review from FDA. NIVA|HF is the first application of VoluMetrix's proprietary venous waveform technology. Read More
Press Release